Cargando…
Employing the CRISPR-Cas System for Clonal Hematopoiesis Research
Clonal hematopoiesis is a state in which substantial fraction of hematopoietic stem cells acquire mutations in specific driver genes and expand in the absence of an overt hematological malignancy. Recent clinical studies have shown that clonal hematopoiesis increases likelihood of hematological mali...
Autores principales: | Ogawa, Hayato, Sano, Soichi, Walsh, Kenneth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360470/ https://www.ncbi.nlm.nih.gov/pubmed/34395722 |
Ejemplares similares
-
Clonal Hematopoiesis: A New Step Linking Inflammation to Heart Failure
por: Yura, Yoshimitsu, et al.
Publicado: (2020) -
Hematopoietic JAK2(V617F)-mediated clonal hematopoiesis: AIM2 understand mechanisms of atherogenesis
por: Sano, Soichi, et al.
Publicado: (2021) -
TP53-mediated therapy-related clonal hematopoiesis contributes to doxorubicin-induced cardiomyopathy by augmenting a neutrophil-mediated cytotoxic response
por: Sano, Soichi, et al.
Publicado: (2021) -
Modeling clonal hematopoiesis in umbilical cord blood cells by CRISPR/Cas9
por: Christen, Friederike, et al.
Publicado: (2021) -
The Cancer Therapy-Related Clonal Hematopoiesis Driver Gene Ppm1d Promotes Inflammation and Non-Ischemic Heart Failure in Mice
por: Yura, Yoshimitsu, et al.
Publicado: (2021)